HDFC PHARMA AND HEALTHCARE FUND REGULAR IDCW REINVESTMENT
- Equity
- Pharma & Healthcare
- Status: Open
Historical NAV & Returns
Calculate Your Returns
HDFC PHARMA AND HEALTHCARE FUND REGULAR IDCW REINVESTMENT
Growth Calculator
SIP Amount
Investment Duration
Step up (Annually)
Stop comparing, start growing. Get expert-made portfolios ready for you.
Fund Overview
₹1,875.89 Cr.
₹100
₹100
INF179KC1HN3
2.11%
No Lock-in
Trailing Returns
View full Return AnalysisAs of February 25, 2026
Risk Analysis
View full Risk Analysis
Suitable for aggressive investments and investors with very high-risk tolerance.
About This Fund
More InformationHDFC PHARMA AND HEALTHCARE FUND REGULAR IDCW REINVESTMENT is a scheme launched by HDFC Mutual Fund on October 04, 2023, and falls under the Pharma & Healthcare fund category. It currently manages an AUM of Rs 1,875.89 crore. The fund permits investments with a minimum SIP of Rs 100 and a lump sum of Rs 100. It charges an expense ratio of 2.11% for managing the portfolio.
Investing Strategy:
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
Performance:
HDFC PHARMA AND HEALTHCARE FUND REGULAR IDCW REINVESTMENT trailing returns over different times are 17.8% (1 year), 0% (3 year) and 0% (5 year). The average annual return of this fund stands at 3.15%.
SIP Amount
Monthly SIP Date
HDFC PHARMA AND HEALTHCARE FUND REGULAR IDCW REINVESTMENT
+10k investors used our Suitability Test to get better returns
Frequently Asked Questions
Everything You Need To Know To Get Started With Confidence